Closing Strong: Rallybio Corp (RLYB) Ends at $0.69, Up 1.19 from Last Close

Kevin Freeman

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

After finishing at $0.68 in the prior trading day, Rallybio Corp (NASDAQ: RLYB) closed at $0.69, up 1.19%. In other words, the price has increased by $1.19 from its previous closing price. On the day, 0.18 million shares were traded. RLYB stock price reached its highest trading level at $0.689 during the session, while it also had its lowest trading level at $0.651.

Ratios:

Our goal is to gain a better understanding of RLYB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.74 and its Current Ratio is at 14.74. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Jefferies Downgraded its Buy to Hold on February 07, 2024, whereas the target price for the stock was revised from $7 to $1.50.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLYB now has a Market Capitalization of 28983454 and an Enterprise Value of -30137546. For the stock, the TTM Price-to-Sale (P/S) ratio is 43.26 while its Price-to-Book (P/B) ratio in mrq is 0.46. Its current Enterprise Value per Revenue stands at -44.714 whereas that against EBITDA is 0.909.

Stock Price History:

The Beta on a monthly basis for RLYB is -1.04, which has changed by -0.2863158 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, RLYB has reached a high of $1.08, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is 2.19%, while the 200-Day Moving Average is calculated to be 34.43%.

Shares Statistics:

The stock has traded on average 240.47K shares per day over the past 3-months and 229760 shares per day over the last 10 days, according to various share statistics. A total of 41.94M shares are outstanding, with a floating share count of 21.63M. Insiders hold about 48.80% of the company’s shares, while institutions hold 22.47% stake in the company. Shares short for RLYB as of 1765756800 were 122587 with a Short Ratio of 0.51, compared to 1763078400 on 174572. Therefore, it implies a Short% of Shares Outstanding of 122587 and a Short% of Float of 0.36000002.

Earnings Estimates

Current recommendations for the stock of the company come from 2.0 analysts. The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.15 and low estimates of -$0.15. Analysts are recommending an EPS of between -$0.22 and -$1.03 for the fiscal current year, implying an average EPS of -$0.49. EPS for the following year is -$1.15, with 3.0 analysts recommending between -$0.66 and -$2.09.

Revenue Estimates

A total of 3 analysts have provided revenue estimates for RLYB’s current fiscal year. The highest revenue estimate was $800k, while the lowest revenue estimate was $636k, resulting in an average revenue estimate of $745.33k. In the same quarter a year ago, actual revenue was $636k

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.